Marie-Claire Fritsch

BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development.

TreeFrog Therapeutics SAS provides stem cell treatment services. It offers its expertise to patients of heart failure, diabetes, traumatic injury, skin burns, dermatitis, Huntington, and Parkinson disease. The company was founded by Maxime Feyeux, Kevin Alessandri, Jean-Luc Treillou, Erwan Bezard, Laurent Cognet, and Pierre Nassoy and is headquartered in Pessac, France.

DNA Script engages in the provision of research and development in biotechnology. It manufactures synthetic deoxyribonucleic acid using enzymatic technology. The company was founded by Thomas Ybert, Sylvain Gariel and Xavier Godron in 2014 and is headquartered in Paris, France.

Owkin France SAS provides artificial intelligence for predictive medicine. The company was founded on September 7, 2016 and is headquartered in Paris, France.

Dynacure SA is a clinical-stage company, which engages in developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Its product includes, DYN101, an antisense oligonucleotide, or ASO, designed to be a disease-modifying medicine for treatment of the majority of ntronuclear myopathies patients with multiple mutations in adult and pediatric populations. The company was founded by Belinda Cowling in 2016 and is headquartered in Illikirch-Graffenstaden, France.

ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France.

Warner Bros. International Television Distribution, Inc. distributes feature films, television and animation programs. It offers services to the international television marketplace (broadcast, pay cable, basic cable, satellite, pay-per-view, video-on-demand, digital platforms, etc.). The company was founded in 1989 and is headquartered in New York, NY.

Optegra UK Ltd. provides ophthalmic services. It offers treatment for cataract, age-related macular degeneration, corneal cross linking and keratoconus and glaucoma. The firm operates hospitals in Birmingham, London, Manchester, Surrey, Solent and Yorkshire. The company was founded in 2006 and is headquartered in London, the United Kingdom.

Tissium SA engages in the development and commercialization of biodegradable sealants and adhesives for invasive surgery. It offers biomimetic wound closure solutions. The company was founded by Bernard J. Gilly, Robert S. Langer, Christophe Bancel, Jeff Karp, Jacques Marescaux, Maria Pereira, and Patrick Houvet in 2013 and is headquartered in Paris, France.

Sofradim Production SAS manufactures medical, surgical and dental equipment. The company is headquartered in Trevoux, France.

Medcura, Inc. develops novel line of hemostatic and wound treatment products. The firm?s products include vascular gel-e, nuisance bleed, chronic wound, and surgical gel-e. The company was founded by Matthew Dowling in January 2013 and is headquartered in Riverdale, MD.

Equipe Zorgbedrijven Nederland BV operates a chain of private clinics. Its specialized in hand and wrist, orthopedic, cosmetic, vaginal, and revalidation care. The company was founded by Jak Dekker in 1995 and is headquartered in Eindhoven, the Netherlands.

Spineart SA operates as a medical device company. The firm designs, develops and promotes solutions to spine surgeons, operating room teams, and patients. It serves in the area of minimally invasive surgery, motion preservation, fusion, biologics, and fractures treatment. The company was founded by Jérôme Levieux and Stéphane Mugnier in 2005 and is headquartered in Geneva, Switzerland.

Heilig Hart Ziekenhuis is a hospital located in Lier, BE. The hospital offers parking, and information about rates and intended users can be found on their website. The hospital staff works to provide care for patients during emergency admissions or day and multi-day stays. Patients can also find information about their stay on the hospital's website. The CEO of the Belgian company is Stefaan Vansteenkiste.

Handicare AS manufactures and supplies technical aids for the elderly and disabled people. Its products include wheelchairs, stair lifts, patient handling and bathroom safety products, personal transfer, and automobile adaptation solutions. The company was founded on November 11, 1992 and is headquartered in Moss, Norway.

Part of Optegra Global Ltd., Optegra International Ltd. functions as an investment holding British company. The company is based in Hildenborough, UK and was founded in 2016.

Gimv (Private Equity) is a Private Equity firm, a subsidiary of Gimv NV (XB: GIMB) founded in 1980. Gimv (Private Equity) is headquartered in Antwerp, Belgium.

Théâtre du Châtelet operates theatre and opera house. It hosts a variety of art forms such as ballet, opera, operetta, musicals and cinema. The company was founded on August 19, 1862 and is headquartered in Paris, France.

LFB Biotechnologies SASU provides plasma-derived medicinal products. The firm undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The company was founded on September 21, 2006 and is headquartered in Courtaboeuf, France.

MAbgène SA is a French company that produces monoclonal antibodies and recombinant proteins through cell culture. The company is based in Alès, France. The company has two CLD platforms available, including a CHO-S platform and their proprietary EMABling® platform. LFB Biotechnologies SASU is a subsidiary of LFB BIOMANUFACTURING, which is ultimately controlled by the Government of France. MAbgène was acquired by LFB Biotechnologies SASU on November 30, 2007 for $4.09 million.

Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France.

VarmX BV is a spin-off from Leiden University Medical Center (LUMC) founded in 2016 by Professor Pieter Reitsma, a world-leading expert in hemostasis and thrombosis. VarmX is based in Leiden, NL. The Dutch company's lead compound, VMX-C001, is a modified recombinant blood factor X developed for the treatment of severe spontaneous bleeding and for the prevention of bleeding during urgent surgery in patients taking oral factor Xa inhibitors (FXa DOACs) as anticoagulation therapy. The company is supported by a strong syndicate of investors. Jan K. Öhrström has been the CEO of the company since 2018.